In this week’s 'Useful Idiots' podcast, mtaibbi and kthalps are joined by biomedical researcher Dr. Robert Gallo to discuss the potential for a COVID-19 vaccine
, and they are doing whatever they can do to not be at all responsive to what the people want,” says Katie.
Dr. Robert Gallo, director of the Institute for Human Virology at the University of Maryland School of Medicine, joins the show to give his take on the prospects for an effective COVID-19 vaccine. Gallo is skeptical of the approach many organizations are taking with antibody vaccines, citing the similarly low efficacy those treatments had with HIV due to the low durability of the antibodies. Dr.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
'Vaccine nationalism': Is it every country for itself?A slew of bilateral deals between governments and drugmakers to secure millions of doses of COVID-19 vaccines is putting at risk a WHO co-led initiative to bulk-buy and equitably distribute the pandemic vaccines around the world
続きを読む »
U.S. To Spend $2.1 Billion On GlaxoSmithKline-Sanofi Covid-19 VaccineThe U.S. agreed to spend $2.1 billion on a joint experimental Covid-19 vaccine from GlaxoSmithKline and Sanofi to supply the nation with an initial 100 million doses by iamsternlicht
続きを読む »
Vaccine Candidate Delivers Protection In A Single Shot (In Monkeys)Two new studies involving monkeys suggest COVID-19 vaccine candidates can provide disease protection after a single injection — but it will take large-scale human trials to know for sure if they work.
続きを読む »
U.S. government to launch 'overwhelming' COVID-19 vaccine campaign by NovemberThe Trump administration anticipates launching a far-reaching promotions campaign by November to encourage Americans to get vaccinated against the coronavirus, contingent on evidence that a successful vaccine will be available roughly by year end, a senior administration official said.
続きを読む »
J&J starts human study of COVID-19 vaccine after promising monkey dataWhen exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study published in the journal Nature. 'This gives
続きを読む »